Blogs

Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany

By Aesthetic Multispecialty Society posted Jul 27, 2020 07:57 AM

  
.
0 comments
0 views

Permalink